An innovative drug treatment that could limit the damage caused by burns and encourage skin tissue regeneration is the focus of a new partnership between West Australian research groups headed by two Australians of the Year. The new class of protein-based drugs, called Phylomer®, has been developed by Phylogica, the first spin out company from the Telethon Institute for Child Health Research, headed by Professor Fiona Stanley. Phylogica announced to the Australian Stock Exchange today that it has signed a development agreement with the McComb Foundation, headed by burns specialist and 2005 Australian of the Year, Clinical Professor Fiona Wood. The deal will progress the use of the cell protection Phylomers® in the treatment of burn injury. Phylogica CEO Dr Stewart Washer said preliminary research results look promising.
